Amneal Pharmaceuticals (AMRX) Misses Q3 EPS by 10c, Lowers FY EPS Guidance
Tweet Send to a Friend
Amneal Pharmaceuticals (: AMRX) reported Q3 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
